Advertisement

Research Article Free access | 10.1172/JCI111771

T cells and probably B cells arise from the malignant clone in chronic myelogenous leukemia.

A A Fauser, L Kanz, K J Bross, and G W Löhr

Find articles by Fauser, A. in: JCI | PubMed | Google Scholar

Find articles by Kanz, L. in: JCI | PubMed | Google Scholar

Find articles by Bross, K. in: JCI | PubMed | Google Scholar

Find articles by Löhr, G. in: JCI | PubMed | Google Scholar

Published March 1, 1985 - More info

Published in Volume 75, Issue 3 on March 1, 1985
J Clin Invest. 1985;75(3):1080–1082. https://doi.org/10.1172/JCI111771.
© 1985 The American Society for Clinical Investigation
Published March 1, 1985 - Version history
View PDF
Abstract

Bone marrow cells from a patient with Ph' positive chronic myelogenous leukemia in chronic phase were cultured for multilineage hematopoietic colonies (CFU-GEMMT), erythroid bursts, and granulocytic colonies. With CFU-GEMMT colonies, T lymphocytes were identified by reaction with monoclonal antibodies Leu-5 and OKT-3; B cells were identified by reaction with B1. All CFU-GEMMT colonies examined contained the Ph' chromosome. Recloned secondary colonies of T cells reacted with Leu-5 and OKT-3 and were Ph' positive. This demonstrates that Ph' positive T lymphocytes were generated from the pluripotential stem cell of this patient. The presence of B cells in the mixed colonies indicates that these may also be derived from the neoplastic clone.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (March 1, 1985): No description
Advertisement
Advertisement